Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 7:00 PM View:  | Marshak Richard Sr.VP, Corp. Dev. & Strategy | Trisalus Life Sciences, Inc. (TLSI) | 14-Nov-24 | Grant | 6,875 | -- | -- | 25% 27.25K to 34.13K | |
| 13-Sep-24 5:43 PM View: | Szela Mary T CEO and President Director | Trisalus Life Sciences, Inc. (TLSI) | 13-Sep-24 | Purchase | 7,295 | $4.97 | $36,254.90 | 2% 377.38K to 384.68K | |
| 13-Sep-24 5:43 PM View: | Szela Mary T CEO and President Director | Trisalus Life Sciences, Inc. (TLSI) | 12-Sep-24 | Private Purchase | 7,520 | $5.20 | $39,104.00 | 2% 369.86K to 377.38K | |
| 12-Sep-24 7:06 PM View: | Szela Mary T CEO and President Director | Trisalus Life Sciences, Inc. (TLSI) | 10-Sep-24 | Private Purchase | 5,000 | $4.97 | $24,850.00 | 1% 364.86K to 369.86K | |
| 10-Sep-24 5:42 PM View: | Martin George Kelly Director | Trisalus Life Sciences, Inc. (TLSI) | 28-Aug-24 | Sale | 9 | $5.50 | $49.50 | (< 1%) 247.19K to 247.18K | |
| 02-Jul-24 8:33 PM View: | Desai Arjun Jj Director | Trisalus Life Sciences, Inc. (TLSI) | 01-Jul-24 | Grant | 74,000 | -- | -- | 36% 203.13K to 277.13K | |
| 14-Feb-24 6:44 PM View: | Szela Mary T CEO and President Director | Trisalus Life Sciences, Inc. (TLSI) | 13-Feb-24 | Grant | 84,899 | -- | -- | 30% 279.96K to 364.86K | |
| 14-Feb-24 6:19 PM View: | Devlin Jodi PRESIDENT, COMMERC. OPERATIONS | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 17,500 | -- | -- | 100% 0 to 17.5K | |
| 14-Feb-24 6:42 PM View: | Marshak Richard Sr.VP, Corp. Dev. & Strategy | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 14,752 | -- | -- | 118% 12.5K to 27.25K | |
| 14-Feb-24 6:13 PM View: | Katz Steven C Chief Medical Officer | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 34,144 | -- | -- | 99% 34.44K to 68.59K | |
| 14-Feb-24 6:36 PM View: | Stevens Jennifer Chief Regulatory Officer | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 14,752 | -- | -- | 82% 18.03K to 32.78K | |
| 14-Feb-24 6:17 PM View: | Murphy Sean Chief Financial Officer Director | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 34,144 | -- | -- | 6% 541.91K to 576.05K | |
| 14-Feb-24 6:39 PM View: | Cox Bryan F. Chief Scientific & Manufact. | Trisalus Life Sciences, Inc. (TLSI) | 12-Feb-24 | Grant | 14,752 | -- | -- | 21% 71.94K to 86.7K | |
| 14-Aug-23 5:58 PM View: | Matlin David J Director | Trisalus Life Sciences, Inc. (TLSI) | 10-Aug-23 | Acquisition (other) | 931,904 | -- | -- | 100% 0 to 931.9K | |
| 27-Jun-23 4:13 PM View: | Medtech Acquisition Sponsor... 10% Owner | Trisalus Life Sciences, Inc. (TLSI) | 26-Jun-23 | Conversion | 6,250,000 | -- | -- | 100% 0 to 6.25M | |
| 14-Jun-23 8:05 PM View: | Magnetar Financial LLC 10% Owner | Trisalus Life Sciences, Inc. (TLSI) | 12-Jun-23 | Disposition (other) | 445,828 | $10.49 | $4,675,000.00 | (39%) 1.15M to 700.0K | 4% |
